In vivo lineage tracing revealed that AOH1996 reduced Bmi1+ CSCs in HNSCC, whereas the combination treatment of AOH1996 and anti-PD1 led to increased elimination of Bmi1+ CSCs (Fig. 4K). Here, BMI1 is linked to head and neck squamous cell carcinoma.